Technetium (99mTc) sulesomab

From Wikipedia, the free encyclopedia
  (Redirected from Sulesomab)
Jump to: navigation, search
Technetium (99mTc) sulesomab
Monoclonal antibody
Type Fab' fragment
Source Mouse
Target NCA-90 (granulocyte cell antigen)
Clinical data
ATC code
Legal status
Legal status
  • AU: Approved
Identifiers
CAS Number
ChemSpider
  • none
 NYesY (what is this?)  (verify)

Technetium (99mTc) sulesomab (trade name LeukoScan) is a mouse monoclonal antibody[1] labelled with technetium-99m, a radionuclide, for imaging with a gamma camera.

It is approved for the imaging of infections and inflammations in patients with suspected osteomyelitis,[2] and is being investigated for other purposes like the detection of soft tissue infections.[3]

References[edit]

  1. ^ WHO Drug Information
  2. ^ EMEA: Summary of product characteristics (LeukoScan)
  3. ^ Quigley, A. M.; Gnanasegaran, G.; Buscombe, J. R.; Hilson, A. J. W. (2008). "Technetium-99m-Labelled Sulesomab (LeukoScan) in the Evaluation of Soft Tissue Infections". Medical Principles and Practice. 17 (6): 447–52. PMID 18836272. doi:10.1159/000151565. 

See also[edit]